Center for Scientific Review; Notice of Closed Meetings, 53702-53703 [2010-21815]
Download as PDF
<![CDATA[
53702
Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices
Period of Replacement Award: The
period of support for the replacement
award is June 1, 2010 to October 31,
2010.
Authority: Section 330(h) of the Public
Health Service Act, 42 U.S.C. 245b.
CDFA Number: 93.703.
Justification for Exception to
Competition: The former grantee, Saint
Vincent’s Catholic Medical Centers of
New York, has relinquished all grants.
Saint Vincent’s Catholic Medical
Centers of New York’s inpatient services
has closed, and Saint Vincent’s Catholic
Medical Center of New York has filed
for bankruptcy under Chapter 11. The
former grantee has requested that HRSA
transfer the Health Center Program
Section 330(h) funds to SPHC in order
to implement and carry out grant
activities originally proposed under
SVCMC funded Section 330(h) grant
applications.
SPHC has been engaged in the
delivery of primary health care services
in the local area and is a current Section
330 grantee who indicated an ability to
assume operations without a disruption
of services.
The short-term transfer of the 330(h)
funds will ensure that critical primary
health care services continue and
remain available to low-income,
underserved, homeless patients with no
interruption in services to the target
population.
FOR FURTHER INFORMATION CONTACT:
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2010–N–0389]
Medical Device User Fee Act; Public
Meeting; Request for Comments;
Amendment of Notice
hsrobinson on DSK69SOYB1PROD with NOTICES
Food and Drug Administration,
HHS.
Notice.
The Food and Drug
Administration (FDA) is announcing an
amendment to the notice of a public
meeting on the reauthorization of the
medical device user fee program. This
meeting was announced in the Federal
SUMMARY:
18:24 Aug 31, 2010
BILLING CODE 4160–01–S
National Institute of Mental Health;
Amended Notice of Meeting
[FR Doc. 2010–21836 Filed 8–31–10; 8:45 am]
VerDate Mar<15>2010
[FR Doc. 2010–21800 Filed 8–31–10; 8:45 am]
National Institutes of Health
Dated: August 26, 2010.
Mary K. Wakefield,
Administrator.
ACTION:
Dated: August 27, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy,
Planning and Budget.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Marquita Cullom-Scott via e-mail at
MCullom-Scott@hrsa.gov or 301–594–
4300.
AGENCY:
Register of August 13, 2010 (75 FR
49502). The amendment is being made
to include the exact meeting location,
previously identified only as the
Washington D.C. metropolitan area.
There are no other changes.
FOR FURTHER INFORMATION CONTACT:
James Swink, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, rm. 1609, Silver Spring,
MD 20993, 301–796–6313, FAX: 301–
847–8121, email:
James.Swink@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of August 13, 2010 (75
FR 49502), FDA announced that a
public meeting on the reauthorization of
the medical device user fee program
would be held on September 14, 2010.
On page 49503, in the first column, the
Location portion of the document is
changed to read as follows:
Location: The meeting will be held at
the Marriott Inn and Conference Center,
University of Maryland University
College (UMUC), 3501 University Blvd.
East, Hyattsville, MD 20783,
www.marriott.com/wasum.
Jkt 220001
Notice is hereby given of a change in
the meeting of the Services
Subcommittee of the Interagency
Autism Coordinating Committee (IACC),
September 13, 2010, 1 p.m. to 4 p.m.,
National Institute of Mental Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room A1/A2,
Rockville, MD 20852, which was
published in the Federal Register on
August 19, 2010, 75 FR 51276.
The meeting will not be Webcast as
originally advertised. The meeting is
open to the public and will still be
accessible through a conference call
phone number. The meeting will be
held in the same place and same time.
Dated: August 25, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–21817 Filed 8–31–10; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Clinical Neuroscience
and Neurodegeneration Study Section,
September 30, 2010, 8 a.m. to October
1, 2010, 5 p.m., Washington Plaza Hotel,
10 Thomas Circle, NW., Washington,
DC, 20005 which was published in the
Federal Register on August 4, 2010, 75
FR 46950–46951.
The meeting will be one day only
September 30, 2010. The meeting time
and location remain the same. The
meeting is closed to the public.
Dated: August 26, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–21816 Filed 8–31–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Developmental Biology.
Date: September 14–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Noni Byrnes, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130,
MSC 7840, Bethesda, MD 20892, (301) 435–
1023, byrnesn@csr.nih.gov.
E:\FR\FM\01SEN1.SGM
01SEN1
hsrobinson on DSK69SOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Immunotherapy.
Date: September 30, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Syed M Quadri, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Cardiovascular and Sleep Epidemiology
Study Section.
Date: October 7–8, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: J. Scott Osborne, PhD,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4114,
MSC 7816, Bethesda, MD 20892, (301) 435–
1782, osbornes@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Molecular
Genetics A Study Section.
Date: October 7–8, 2010.
Time: 8:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance M Street Hotel, 1143
New Hampshire Avenue, NW., Washington,
DC 20037.
Contact Person: Michael M Sveda, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1114,
MSC 7890, Bethesda, MD 20892, 301–435–
3565, svedam@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Radiation Oncology.
Date: October 7, 2010.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Syed M. Quadri, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Urologic and Kidney Development and
Genitourinary Diseases Study Section.
Date: October 8, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
18:24 Aug 31, 2010
Jkt 220001
Place: Crowne Plaza Washington National
Airport, 1489 Jefferson Davis Highway,
Arlington, VA 22202.
Contact Person: Ryan G. Morris, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, morrisr@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Musculoskeletal Rehabilitation Sciences
Study Section.
Date: October 8, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Jo Pelham, BA, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4102, MSC 7814, Bethesda, MD
20892, (301) 435–1786, pelhamj@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Host Interactions with Bacterial Pathogens
Study Section.
Date: October 8, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 5 Hotel, 711 Eastern Avenue,
Baltimore, MD 21202.
Contact Person: Fouad A El-Zaatari, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7808, Bethesda, MD 20892, (301) 435–
1149, elzaataf@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 26, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–21815 Filed 8–31–10; 8:45 am]
53703
Place: The teleconference will originate at
the CDC.
Status: Open to the public. Teleconference
access limited only by the availability of
telephone ports. The public is welcome to
participate during the public comment
period, which is tentatively scheduled from
2:45 p.m. to 2:50 p.m. To participate in the
teleconference please dial (877) 394–7734
and enter conference code 9363147.
Purpose: The Subcommittee will provide
recommendations for consideration to the
Advisory Committee to the Director on
strategic and other broad issues facing CDC.
Matters to be Discussed: Policy brief on
health equity and social determinants of
health; update on collaboration with the CDC
Health Equity Workgroup; CDC Director’s
Annual Health Disparity Report; and briefing
on the realignment of the CDC Office of
Minority Health and Health Disparities.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Walter W. Williams, M.D., M.P.H.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600 Clifton
Road, NE., M/S E–67, Atlanta, Georgia 30333.
Telephone (404) 498–2310, E-mail:
www1@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: August 24, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–21803 Filed 8–31–10; 8:45 am
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)—Health Disparities
Subcommittee (HDS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC announces
the following meeting of the
aforementioned subcommittee:
Time and Date: 2 p.m.–3 p.m., September
23, 2010.
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\01SEN1.SGM
01SEN1
]]>Agencies
[Federal Register Volume 75, Number 169 (Wednesday, September 1, 2010)]
[Notices]
[Pages 53702-53703]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21815]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Developmental Biology.
Date: September 14-15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Noni Byrnes, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892, (301) 435-
1023, byrnesn@csr.nih.gov.
[[Page 53703]]
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cancer Immunotherapy.
Date: September 30, 2010.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Syed M Quadri, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301-435-
1211, quadris@csr.nih.gov.
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Cardiovascular and Sleep Epidemiology Study
Section.
Date: October 7-8, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: J. Scott Osborne, PhD, MPH, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4114, MSC 7816, Bethesda, MD
20892, (301) 435-1782, osbornes@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Molecular Genetics A Study Section.
Date: October 7-8, 2010.
Time: 8:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue,
NW., Washington, DC 20037.
Contact Person: Michael M Sveda, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1114, MSC 7890, Bethesda, MD 20892, 301-435-
3565, svedam@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Radiation Oncology.
Date: October 7, 2010.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Syed M. Quadri, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301-435-
1211, quadris@csr.nih.gov.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group; Urologic and Kidney Development and
Genitourinary Diseases Study Section.
Date: October 8, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Crowne Plaza Washington National Airport, 1489 Jefferson
Davis Highway, Arlington, VA 22202.
Contact Person: Ryan G. Morris, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 20892, 301-435-
1501, morrisr@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Musculoskeletal Rehabilitation Sciences
Study Section.
Date: October 8, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Jo Pelham, BA, Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 4102, MSC 7814, Bethesda, MD 20892, (301) 435-1786,
pelhamj@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group; Host Interactions with Bacterial Pathogens
Study Section.
Date: October 8, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202.
Contact Person: Fouad A El-Zaatari, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186, MSC 7808, Bethesda, MD
20892, (301) 435-1149, elzaataf@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: August 26, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-21815 Filed 8-31-10; 8:45 am]
BILLING CODE 4140-01-P
